Stem Hldgs Financials
This page shows Stem Hldgs (STMH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Stem Hldgs passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
For every $1 of reported earnings, Stem Hldgs generates $0.06 in operating cash flow (-$1.2M OCF vs -$19.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Stem Hldgs earns $-3.0 in operating income for every $1 of interest expense (-$3.7M vs $1.2M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Stem Hldgs reported -$19.0M in net income in fiscal year 2023. This represents a decrease of 9.5% from the prior year.
Stem Hldgs earned $-7.67 per diluted share (EPS) in fiscal year 2023. This represents an increase of 1.0% from the prior year.
Cash & Balance Sheet
Stem Hldgs held $961K in cash against $1.1M in long-term debt as of fiscal year 2023.
Stem Hldgs had 281M shares outstanding in fiscal year 2023. This represents an increase of 12258.0% from the prior year.
Margins & Returns
Capital Allocation
STMH Income Statement
| Metric | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | $4.6M-0.8% | $4.7M-3.2% | $4.8M+2.3% | $4.7M-2.3% | $4.8M+0.1% | $4.8M-2.6% | $4.9M |
| Cost of Revenue | N/A | $2.8M-15.8% | $3.3M-17.4% | $4.0M+6.9% | $3.7M+7.1% | $3.5M-7.8% | $3.8M+11.8% | $3.4M |
| Gross Profit | N/A | $1.0M+78.6% | $584K+1001.9% | $53K-82.1% | $296K-55.9% | $671K+97.4% | $340K-58.3% | $816K |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | $2.1M-1.3% | $2.1M-11.1% | $2.4M+144.9% | -$5.3M-308.2% | $2.6M-7.1% | $2.7M-20.1% | $3.4M |
| Operating Income | N/A | -$1.9M-6.5% | -$1.8M+33.3% | -$2.7M-173.2% | $3.7M+244.2% | -$2.5M+26.8% | -$3.5M+29.0% | -$4.9M |
| Interest Expense | N/A | $253K-57.1% | $590K+105.6% | $287K+537.8% | $45K-81.8% | $247K+37.2% | $180K+1.1% | $178K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | -$1.1M+65.7% | -$3.2M-5.4% | -$3.1M+70.4% | -$10.4M-2020.7% | $540K+115.6% | -$3.5M+14.6% | -$4.1M |
| EPS (Diluted) | N/A | $0.00 | N/A | N/A | N/A | $0.00 | N/A | N/A |
STMH Balance Sheet
| Metric | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.3M-48.0% | $25.7M-2.0% | $26.2M-8.7% | $28.7M-7.3% | $31.0M-26.1% | $41.9M+2.7% | $40.8M-6.8% | $43.8M |
| Current Assets | $13.3M+228.7% | $4.1M+19.1% | $3.4M-12.1% | $3.9M-87.5% | $31.0M+298.5% | $7.8M+23.4% | $6.3M-24.4% | $8.3M |
| Cash & Equivalents | $961K-43.6% | $1.7M+62.9% | $1.0M+13.6% | $921K-39.6% | $1.5M-55.2% | $3.4M+169.8% | $1.3M-61.3% | $3.3M |
| Inventory | N/A | $1.3M-6.6% | $1.4M-30.7% | $2.0M-24.8% | $2.7M-13.8% | $3.1M-2.5% | $3.2M-10.3% | $3.5M |
| Accounts Receivable | N/A | $267K+9.0% | $245K+28.3% | $191K-39.0% | $313K+20.4% | $260K-16.1% | $310K+33.6% | $232K |
| Goodwill | N/A | $1.5M0.0% | $1.5M0.0% | $1.5M0.0% | $1.5M-79.5% | $7.4M0.0% | $7.4M0.0% | $7.4M |
| Total Liabilities | $14.0M-3.4% | $14.5M-0.7% | $14.6M+0.3% | $14.5M+4.2% | $13.9M-4.9% | $14.7M+3.8% | $14.1M+1.6% | $13.9M |
| Current Liabilities | $14.0M+126.8% | $6.2M-14.2% | $7.2M+3.1% | $7.0M-50.0% | $13.9M+124.3% | $6.2M-29.6% | $8.8M+26.4% | $7.0M |
| Long-Term Debt | $1.1M0.0% | $1.1M-51.7% | $2.2M0.0% | $2.2M0.0% | $2.2M+21.9% | $1.8M+204.2% | $600K-71.4% | $2.1M |
| Total Equity | -$1.7M-117.7% | $9.7M-4.4% | $10.2M-20.0% | $12.7M-18.3% | $15.6M-39.7% | $25.8M+2.6% | $25.2M-11.4% | $28.4M |
| Retained Earnings | -$152.1M-8.3% | -$140.5M-0.8% | -$139.4M-2.4% | -$136.2M-2.3% | -$133.1M-8.4% | -$122.7M+0.4% | -$123.3M-2.9% | -$119.8M |
STMH Cash Flow Statement
| Metric | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $345K+156.7% | -$609K-105.7% | -$296K+56.1% | -$675K-241.5% | $477K+133.4% | -$1.4M+29.6% | -$2.0M-3.2% | -$2.0M |
| Capital Expenditures | N/A | N/A | N/A | N/A | $9K-18.2% | $11K-83.3% | $66K-48.8% | $129K |
| Free Cash Flow | N/A | N/A | N/A | N/A | $468K+132.5% | -$1.4M+31.3% | -$2.1M0.0% | -$2.1M |
| Investing Cash Flow | N/A | $876K | N/A | N/A | -$1.8M-152.9% | $3.3M+2381.3% | $134K+203.1% | -$130K |
| Financing Cash Flow | $406K+3.8% | $391K+12.4% | $348K+383.3% | $72K+112.1% | -$593K-343.0% | $244K+332.4% | -$105K+2.8% | -$108K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
STMH Financial Ratios
| Metric | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | 22.5%+10.0pp | 12.5%+11.4pp | 1.1%-5.2pp | 6.3%-7.6pp | 13.9%+6.9pp | 7.1%-9.4pp | 16.5% |
| Operating Margin | N/A | -41.1%-2.8pp | -38.3%+17.3pp | -55.5%-133.2pp | 77.7%+130.3pp | -52.6%+19.4pp | -72.0%+26.9pp | -98.9% |
| Net Margin | N/A | -24.0%+45.3pp | -69.3%-5.7pp | -63.6%+156.5pp | -220.1%-231.3pp | 11.2%+83.3pp | -72.1%+10.1pp | -82.3% |
| Return on Equity | N/A | -11.4%+20.4pp | -31.8%-7.7pp | -24.1%+42.5pp | -66.7%-68.8pp | 2.1%+15.9pp | -13.8%+0.5pp | -14.3% |
| Return on Assets | N/A | -4.3%+8.0pp | -12.3%-1.7pp | -10.7%+22.8pp | -33.5%-34.8pp | 1.3%+9.8pp | -8.5%+0.8pp | -9.3% |
| Current Ratio | 0.95+0.3 | 0.66+0.2 | 0.47-0.1 | 0.56-1.7 | 2.22+1.0 | 1.25+0.5 | 0.71-0.5 | 1.19 |
| Debt-to-Equity | -0.63-0.7 | 0.11-0.1 | 0.22+0.0 | 0.17+0.0 | 0.14+0.1 | 0.07+0.0 | 0.02-0.1 | 0.07 |
| FCF Margin | N/A | N/A | N/A | N/A | 9.9%+39.8pp | -29.9%+13.7pp | -43.5%-1.1pp | -42.4% |
Note: Shareholder equity is negative (-$1.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.95), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
Is Stem Hldgs profitable?
No, Stem Hldgs (STMH) reported a net income of -$19.0M in fiscal year 2023.
How much debt does Stem Hldgs have?
As of fiscal year 2023, Stem Hldgs (STMH) had $961K in cash and equivalents against $1.1M in long-term debt.
What is Stem Hldgs's operating cash flow?
Stem Hldgs (STMH) generated -$1.2M in operating cash flow during fiscal year 2023, representing cash generated from core business activities.
What are Stem Hldgs's total assets?
Stem Hldgs (STMH) had $13.3M in total assets as of fiscal year 2023, including both current and long-term assets.
What is Stem Hldgs's current ratio?
Stem Hldgs (STMH) had a current ratio of 0.95 as of fiscal year 2023, which is below 1.0, which may suggest potential liquidity concerns.
What is Stem Hldgs's debt-to-equity ratio?
Stem Hldgs (STMH) had a debt-to-equity ratio of -0.63 as of fiscal year 2023, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Stem Hldgs's return on assets (ROA)?
Stem Hldgs (STMH) had a return on assets of -142.5% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.
What is Stem Hldgs's cash runway?
Based on fiscal year 2023 data, Stem Hldgs (STMH) had $961K in cash against an annual operating cash burn of $1.2M. This gives an estimated cash runway of approximately 9 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Stem Hldgs's debt-to-equity ratio negative or unusual?
Stem Hldgs (STMH) has negative shareholder equity of -$1.7M as of fiscal year 2023, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Stem Hldgs's Piotroski F-Score?
Stem Hldgs (STMH) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Stem Hldgs's earnings high quality?
Stem Hldgs (STMH) has an earnings quality ratio of 0.06x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Stem Hldgs cover its interest payments?
Stem Hldgs (STMH) has an interest coverage ratio of -3.0x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.